0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

Statement on the Status of Measles Vaccines

JAMA. 1963;183(13):1112-1113. doi:10.1001/jama.1963.63700130028018.
Text Size: A A A
Published online

TO MAKE AVAILABLE to the health profession concise information regarding the status of inactivated and live, attenuated measles-virus vaccines and their appropriate application, an Advisory Committee to the Surgeon General was convened on Feb 25 to appraise the available data. Considerable research has been carried out by many investigators in developing and testing these vaccines. Additional studies are planned or are in progress to define and clarify many practical questions relating to their use, such as optimal immunization schedules, relative efficacy and safety, and others. The present report is an interim statement based on all of the current, available information.

A. Live, Attenuated Measles-Virus Vaccine (Edmonston Strain)  Developed in the laboratory of Dr. John Enders, this vaccine, prepared in chick-embryo tissue culture, was first tested in 1958 and since has been given to approximately 25,000 persons in the United States, either alone or in combination with gamma globulin. The

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();